Trade Summary

3 days ago, Russell Steven Jon, serving as Chief Medical Officer at Beta Bionics, Inc. (BBNX), sold 4,222 shares at $12.61 per share, for a total transaction value of $53,227.18. Following this transaction, Russell Steven Jon now holds 173,849 shares of BBNX.

This sale represents a 2.37% decrease in Russell Steven Jon's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, June 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 3, 2026 at 6:00 PM ET, 1 day after the trade was made.

Beta Bionics, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.